SWM
TGTX icon

Spire Wealth Management’s TG Therapeutics TGTX Stock Holding History

Spire Wealth Management’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.3K Hold
400
– – ﹤0.01% 1541
2025
Q4 		$11.9K Hold
400
– – ﹤0.01% 1651
2025
Q3 		$14.4K Hold
400
– – ﹤0.01% 1628
2025
Q2 		$14.4K Sell
400
-22,750
-98% -$847K ﹤0.01% 1610
2025
Q1 		$913K Buy
23,150
+22,750
+5,688% +$765K 0.03% 423
2024
Q4 		$12K Buy
+400
New +$11.5K ﹤0.01% 1793
2022
Q1 		– Sell
-80
Closed -$2K – 2853
2021
Q4 		$2K Sell
80
-657
-89% -$17.1K ﹤0.01% 2806
2021
Q3 		$25K Hold
737
– – ﹤0.01% 1770
2021
Q2 		$29K Buy
737
+298
+68% +$11.7K ﹤0.01% 1726
2021
Q1 		$36K Buy
+439
New +$21.1K ﹤0.01% 1893

Other funds holding TGTX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Jane Street
Jane Street New York $93.1B AUM 61.18% 1-Year Est. Return